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to be weaned off hemodialysis along with
the benefit of concurrent amelioration of
renovascular hypertension.
Conclusion: For select patients with
RAO there can benefits, such as achieving
dialysis independence and stabilization of
renovascular hypertension, by attaining
revascularization of the renal arteries despite
prolonged time of ischemia. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.041

No Survival Advantage Exists for Patients Undergoing Loop Ileostomy for Clostridium difficile Colitis
Bradley R. Hall, Andrew Cannon, Pranita Atri, Christopher S. Wichman, Lynette M. Smith, Apar K.
Ganti, Chandrakanth Are, Aaron R. Sasson, Sushil Kumar, Surinder K. Batra

Mentor: Dmitry Oleynikov
Program: General Surgery
Background & Objectives: Loop ileostomy
(LI) remains an unproved alternative to total
abdominal colectomy (TAC) for patients
with Clostridium difficile infection (CDI).
We aim to compare outcomes between loop
ileostomy and total abdominal colectomy for
Clostridium difficile infection using a national
database.
Methods: The 2011-2016 ACS-NSQIP
database was queried for patients who

underwent LI or TAC for CDI. Patients with
high outlying age, LOS, and operative time
were excluded. Statistics were performed
using IBM SPSS and NCSS PASS 11.

frequent in the TAC cohort (54% vs. 19%,
p<0.001). Four patients in the LI cohort
required reoperation; however, none required
colectomy.

Results: Of 457 patients identified, 47
underwent LI. Predicted morbidity was higher
in the TAC cohort (62% vs. 37%, p<0.001).
Patients in the LI cohort experienced fewer
complications (72% vs. 87%, p=0.021);
however, mortality did not differ between
LI (36%) and TAC (31%) cohorts. Blood
transfusions were more than twice as

Conclusions: Compared to TAC, LI does not
improve survival for patients who require
surgical intervention for CDI. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.042

Advanced Pancreatic Cancer: A Meta-Analysis of Clinical Trials over Thirty Years
Bradley R. Hall, Jennifer A. Leinicke, Priscila R. Armijo, Lynette M Smith, Sean J. Langenfeld, Dmitry Oleynikov

Mentor: Surinder Batra
Program: General Surgery
Background & Objectives: In contrast to
other cancers, survival rates for pancreatic
ductal adenocarcinoma (PDAC) have
improved but minimally over the past thirty
years. The aim of this study was to perform a
meta-analysis of clinical trials published since
1986 to determine trends in median overall
survival in primarily metastatic PDAC.
Methods: All Phase 2-4 clinical trials
published during or after 1986 investigating
first-line systemic chemotherapy in metastatic
PDAC were included in the meta-analysis.
Publications obtained through PubMed and

www.ClinicalTrials.gov were cross-referenced
to identify additional trials. Trials enrolling
fewer than 50% of study participants with
metastatic disease were excluded.
Results: Of 19,488 patients enrolled in 151
clinical trials, 84% had metastatic disease
and 16% had locally advanced pancreatic
cancer. In clinical trials published from 1986
to 2016, the weighted median overall survival
(wMOS) increased by 3.0 months. The
median wMOS was higher in combination
therapy (7.31 months, IQR 5.4 to 8.5)
compared to non-gemcitabine, single-agent
therapy (4.76 months, IQR 3.5 to 6.0),
gemcitabine monotherapy (6.48 months, IQR

5.9 to 7.2), and gemcitabine plus single-agent
therapy (7.09 months, IQR 6.3 to 8.2). Of all
regimens used in more than one study arm,
FOLFIRINOX had the highest wMOS (10.9
months).
Conclusions: Regardless of treatment
regimen, survival rates in PDAC have
minimally improved over time. Of drugs
used in two or more study arms, only
FOLFIRINOX has a wMOS greater than ten
months. Emphasis should, therefore, be placed
on identification of novel targets that promote
early diagnosis and intervention. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.043
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Background: The management and prognosis
of pancreatic adenocarcinoma varies
depending on the location of the primary
lesion within the pancreas. There is a paucity
of data on survival trends in pancreatic
adenocarcinoma based on the location. The
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aim of this study was to analyze the national
trends in survival for patients with pancreatic
adenocarcinoma based on the location of the
primary lesion.
Methods: The Surveillance, Epidemiology,
and End Results (SEER) database (SEER 17,
1973-2007) was used to identify patients with
pancreatic cancer located in the head (C25.0),
body (C25.1), or tail (C25.2). SEER*Stat
Oral Presentations

6.6.2 was used to calculate 5-year survival
data. To stabilize rates, we used 5-year cohorts
when calculating trends.
Results: A total of 89,733 patients were
included in the study. The overall 5-year
survival, inclusive of all locations and
treatment approaches was is 5.4% (95% CI
5.2-5.6%). For lesions in the head, body and
tail the overall 5-year survival, inclusive of
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all treatment approaches, was 5.2% (95% CI
5-5.5%), 3.9% (95% CI 3.4-4.4%) and 7.8%
(95% CI 7.2-8.5%) respectively. For patients
that underwent surgery, the 5-year survival
for patients with lesions in all locations, head,
body and tail was 18.8%, 15.9%, 23.8%
and 33.8% respectively. When analyzing
trends we noted a significant improvement in
survival for patients that underwent operative

intervention. Comparing the time periods
from 1977-1981 versus 2002-2006, the 5-year
survival for surgical patients improved for
all locations (9.2% to 22.6%, p<0.05) and
also for lesions in the head (8.3% to 19.3%,
p<0.05), body (6.7% to 26%, p<0.05) and tail
(14.7% to 40.7%, p<0.05).

patients with pancreatic cancer treated by
operative intervention. This improvement in
survival was more pronounced for patients
with primary lesions located in the body and
tail. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.044

Conclusion: The results of our study
demonstrate an improvement in survival for

Global Trends in Esophageal Cancer

Gautam K. Malhotra, Ujwal Yanal, Advaitaa Ravipati, Matthew Follet, M. Vijayakumar, Chandrakanth Are

Mentor: Chandrakanth Are
Program: General Surgery
Background & Objectives: Esophageal
Cancer (EC) is a lethal malignancy with poor
prognosis and significant variations in the
incidence, mortality, and histopathology based
on geographic regions. The aim of this study
was to quantitatively analyze these variations
to identify patterns and areas for further
research.
Methods: We utilized the GLOBOCAN 2012,
and Cancer Incidence in five Continents,

Volume X (CI5X) database to analyze
variations in EC incidence and mortality.
Results: We found the EC incidence and
mortality is geographically varied with a
particularly high burden in East Asia and
Eastern/Southern Africa where esophageal
squamous cell carcinoma (SCC) predominates
over adenocarcinoma (AC). Interestingly,
there is a dichotomy between the high
incidence of esophageal SCC in East Africa
and low incidence in West Africa. The global
incidence and mortality from EC is expected
to rise in the coming decades. Asia, and

China in particular, will continue to be the
areas most burdened by EC, while Africa
is expected to surpass the incidence and
mortality rates of Europe.
Conclusions: The global burden of EC
is expected to rise in the coming years.
Understanding the geographic, environmental,
and genetic contributors to the development
of EC will be essential in combating its
prevalence. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.045

Outcomes of Intragastric Balloon Placements: An Analysis of the 2016 MBSAQIP Database
Bhavani Pokala, Priscila Armijo, Dmitry Oleynikov

Mentor: Dmitry Oleynikov
Program: General Surgery
Background & Objectives: Intragastric
balloon placement is an approved weightloss procedure with a lower BMI cutoff than
bariatric surgery. The objective of this study
was to examine the frequency and outcomes
of balloon placements in 2016.
Methods: The MBSAQIP database was
analyzed for adults who underwent elective,
endoscopic intragastric balloon placement.
Emergent cases, patients with previous foregut
surgery and those unable to be followed for
30 days were excluded. Comparisons were
made between placements performed by GI

and surgery. Analysis performed using SPSS
v25.0, α=.05.
Results: Our study included 445 patients.
Majority were female (80%) and Caucasian
(90.6%). Median age and BMI were 49.0
(IQR 15.4) and 35.7 (IQR 6.46), respectively.
Prevalence of medically treated hypertension
was 30.8%, hyperlipidemia 18.9%, GERD
20.4%, and diabetes 12.6% (insulin and
non-insulin dependent). Mean operative
time was 15.48 ± 9.89 minutes. No 30-day
mortalities were reported. 70 balloons were
placed by GI and 375 by surgery. There was a
significantly higher rate of readmission for GI
7.1% vs 1.9% surgery (p=.027). No significant
difference was seen for rates of post-operative

dehydration (GI: 7.1% vs surgery: 7.2%;
p=1.000), emergency room encounters (GI:
14.0% vs surgery: 4.0%; p=.486), 30-day
reoperations (GI: 0.0% vs surgery: 0.8%;
p=1.000), and 30-day reinterventions (GI:
5.7% vs surgery 2.4%; p=.132).
Conclusions: The majority of patients
undergoing intragastric balloon placement
fall within obesity class 1 or 2 and have low
rates of comorbidities. The procedure can be
performed by gastroenterology or surgery at
bariatric centers with similar outcomes. 
https://doi.org/10.32873/unmc.dc.gmerj.1.1.046

Development of a Porcine Model of Severe Noncompressible Truncal Hemorrhage
Ujwal Yanala, Jason Johanning, Iraklis Pipinos, William Velander, Mark Carlson

Mentor: Mark Carlson
Program: General Surgery
Introduction: Noncompressible truncal
hemorrhage and brain injury account for most
early mortality in military personnel on the
battlefield. Currently there is no effective
treatment for noncompressible truncal
hemorrhage, other than rapid evacuation to
a surgical facility. We intended to develop a
porcine model of noncompressible truncal

hemorrhage so that we might be able to
develop new treatments for this clinical
problem.
Methods: Swine (boars, 3 months, 32-34 kg)
underwent one of three injury types: 1) central
stellate injury, just anterior to suprahepatic
inferior vena cava (N=6); 2) excision of a
portal vein branch distal to the main trunk
(N=5); or 3) near-transection of the left lateral
lobe (LLL) of the liver at its base, which
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cut the hepatic and portal veins to this lobe
(N=12). The midline incision was towel
clipped immediately after injury, and animals
were monitored for 60 min or until death.
Resuscitation was performed with warm LR
(max volume = 100 mL/kg), with a target
MAP set at 80% of pre-injury MAP.
Results: The starting weight, MAP,
hemoglobin, arterial pH, INR, and pre-injury
blood loss did not differ among groups (p
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